Chinook Therapeutics, Inc. Net Profit Margin 2015-2023 | KDNY
Chinook Therapeutics, Inc. net profit margin from 2015 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-06-30 | $0.01B | $-0.25B | -3514.29% |
| 2023-03-31 | $0.01B | $-0.22B | -3616.67% |
| 2022-12-31 | $0.01B | $-0.19B | -2700.00% |
| 2022-09-30 | $0.06B | $-0.12B | -207.02% |
| 2022-06-30 | $0.05B | $-0.09B | -172.22% |
| 2022-03-31 | $0.05B | $-0.10B | -181.48% |
| 2021-12-31 | $0.05B | $-0.10B | -201.96% |
| 2021-09-30 | $0.00B | $-0.16B | -16100.00% |
| 2019-09-30 | $0.02B | $-0.09B | -523.53% |
| 2019-06-30 | $0.02B | $-0.09B | -606.67% |
| 2019-03-31 | $0.01B | $-0.10B | -738.46% |
| 2018-12-31 | $0.02B | $-0.09B | -587.50% |
| 2018-09-30 | $0.02B | $-0.09B | -552.94% |
| 2018-06-30 | $0.02B | $-0.10B | -533.33% |
| 2018-03-31 | $0.02B | $-0.09B | -433.33% |
| 2017-12-31 | $0.02B | $-0.09B | -511.11% |
| 2017-09-30 | $0.02B | $-0.10B | -533.33% |
| 2017-06-30 | $0.02B | $-0.11B | -588.89% |
| 2017-03-31 | $0.05B | $-0.09B | -166.67% |
| 2016-12-31 | $0.05B | $-0.09B | -180.39% |
| 2016-09-30 | $0.08B | $-0.06B | -72.84% |
| 2016-06-30 | $0.10B | $-0.02B | -23.96% |
| 2016-03-31 | $0.07B | $-0.05B | -76.12% |
| 2015-12-31 | $0.07B | $-0.04B | -53.42% |
| 2015-09-30 | $0.05B | $-0.04B | -87.76% |
| 2015-06-30 | $0.03B | $-0.05B | -153.13% |
| 2015-03-31 | $0.02B | $-0.03B | -117.39% |
| 2014-12-31 | $0.01B | $-0.02B | -138.46% |
